Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 3/20 | 0.63 |
| ▸ | POLB | P06746 | 2/20 | 0.63 |
| ▸ | RAB9A | P51151 | 2/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.59 |
| ▸ | MAPT | P10636 | 5/20 | 0.59 |
| ▸ | HTT | P42858 | 4/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.59 |
| ▸ | ATM | Q13315 | 2/20 | 0.59 |
| ▸ | CASP1 | P29466 | 2/20 | 0.59 |
| ▸ | TP53 | P04637 | 1/20 | 0.59 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.59 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.59 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 4/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.49 |
| ▸ | CASP3 | P42574 | 1/20 | 0.47 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9429245 | 0.83 | ALDH1A1 (0.59) | NPC1POLBRAB9AALDH1A1MAPT | |
| SCHEMBL21507918 | 0.80 | NPC1 (0.65) | NPC1POLBRAB9AALDH1A1MAPT | |
| SCHEMBL2010960 | 0.78 | NPC1 (0.63) | NPC1POLBRAB9AALDH1A1MAPT | |
| SCHEMBL1818445 | 0.77 | CYP3A4 (0.59) | NPC1POLBRAB9AALDH1A1MAPT | |
| SCHEMBL29757180 | 0.77 | NPC1 (1.00) | NPC1POLBRAB9AALDH1A1MAPT | |
| SCHEMBL30743 | 0.77 | NPC1 (1.00) | NPC1POLBRAB9AALDH1A1MAPT | |
| SCHEMBL3284522 | 0.77 | MAPT (0.61) | NPC1POLBRAB9AALDH1A1MAPT | |
| SCHEMBL29350099 | 0.76 | NPC1 (0.65) | NPC1POLBRAB9AALDH1A1MAPT | |
| SCHEMBL150476 | 0.76 | NPC1 (0.65) | NPC1POLBRAB9AALDH1A1MAPT | |
| SCHEMBL3694131 | 0.76 | NPC1 (0.65) | NPC1POLBRAB9AALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4241800-B1 | ABSORBABLE IMPLANTABLE MEDICAL DEVICE MADE OF IRON-BASED ALLOY | BIOTYX MEDICAL SHENZHEN CO LTD (CN) | 2025-08-27 | — | — | EP | claimed |
| EP-3400969-B1 | IMPLANTED DEVICE | BIOTYX MEDICAL SHENZHEN CO LTD (CN) | 2021-05-19 | — | — | EP | claimed |
| EP-1351979-B1 | REGULATED ACTIVATION OF CELL-MEMBRANE RECEPTORS BY METAL-CHELATING AGONISTS | SMITHKLINE BEECHAM CORP (US) | 2008-01-16 | — | — | EP | claimed |
| EP-0906947-B1 | Indolocarbazole electroluminescent devices | XEROX CORP (US) | 2003-05-21 | — | — | EP | claimed |
| EP-0661324-B1 | Hight-initiated cationic curable epoxyresin compositions and their use | DELO INDUSTRIEKLEBSTOFFE GMBH (DE) | 2000-07-12 | — | — | EP | claimed |
| EP-0661324-A1 | Hight-initiated cationic curable epoxyresin compositions and their use | THERA Patent GmbH & Co. KG Gesellschaft für industrielle Schutzrechte (DE) | 1995-07-05 | — | — | EP | claimed |
| US-4036834-A | ANTIBACTERIAL | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JA) | 1977-07-19 | — | — | US | claimed |
| US-20250223291-A1 | IMIDAZOTRIAZINES AND IMIDAZOPYRIMIDINES AS KINASE INHIBITORS | INCYTE CORPORATION | 2025-07-10 | — | — | US | disclosed |
| US-12084449-B2 | Imidazotriazines and imidazopyrimidines as kinase inhibitors | INCYTE HOLDINGS CORPORATION (US) | 2024-09-10 | — | — | US | disclosed |
| US-20240067664-A1 | Organic Compound, Light-Emitting Device, Display Device, Electronic Device, Light-Emitting Apparatus, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2024-02-29 | — | — | US | disclosed |
| US-20230002392-A1 | Imidazotriazines and Imidazopyrimidines as Kinase Inhibitors | INCYTE CORPORATION | 2023-01-05 | — | — | US | disclosed |
| US-11261191-B2 | Imidazotriaines and imidazopyrimidines as kinase inhibitors | INCYTE HOLDINGS CORPORATION (US) | 2022-03-01 | — | — | US | disclosed |
| EP-3290525-B1 | METHOD FOR SCREENING DRUG AND THERAPEUTIC TARGET USED FOR TREATING ALZHEIMER'S DISEASE | JIANGSU NUO BETA PHARMACEUTICAL TECH CO LTD (CN) | 2022-02-23 | — | — | EP | disclosed |
| WO-1998023581-A1 | BENZAMIDOALDEHYDES AND THEIR USE AS CYSTEINE PROTEASE INHIBITORS | BASF AKTIENGESELLSCHAFT (DE) | 1998-06-04 | — | — | WO | disclosed |
| EP-0688804-A2 | Cationically hardening multicomponent epoxy resin compositions and a process for their cure | THERA Patent GmbH & Co. KG Gesellschaft für industrielle Schutzrechte (DE) | 1995-12-27 | — | — | EP | disclosed |
| EP-0661324-A1 | Hight-initiated cationic curable epoxyresin compositions and their use | THERA Patent GmbH & Co. KG Gesellschaft für industrielle Schutzrechte (DE) | 1995-07-05 | — | — | EP | disclosed |
| EP-0048834-B1 | METHOD FOR MEASUREMENT OF TRACE ENZYMES | FUJI PHOTO FILM CO., LTD. (JP) | 1985-06-19 | — | — | EP | disclosed |
| US-4414325-A | PHOTOGRAPHY | FUJI PHOTO FILM CO., LTD. (JP) | 1983-11-08 | — | — | US | disclosed |
| EP-0048834-A1 | Method for measurement of trace enzymes | FUJI PHOTO FILM CO., LTD. (JP) | 1982-04-07 | — | — | EP | disclosed |
| US-3956345-A | POLYESTER | CIBA-GEIGY AG (CH) | 1976-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230002392-A1 | Imidazotriazines and Imidazopyrimidines as Kinase Inhibitors | ERBB2, MERTK, ABL1 | NPC1 3650/4885POLB 3413/4885RAB9A 3414/4885 |
| US-20250223291-A1 | IMIDAZOTRIAZINES AND IMIDAZOPYRIMIDINES AS KINASE INHIBITORS | ERBB2, MERTK, ABL1 | NPC1 3650/4885POLB 3413/4885RAB9A 3414/4885 |
| US-12084449-B2 | Imidazotriazines and imidazopyrimidines as kinase inhibitors | ERBB2, MERTK, ABL1 | NPC1 3650/4885POLB 3413/4885RAB9A 3414/4885 |
| US-11261191-B2 | Imidazotriaines and imidazopyrimidines as kinase inhibitors | MET, RET, ERBB2 | NPC1 3792/4885POLB 3147/4885RAB9A 2986/4885 |
| US-20240067664-A1 | Organic Compound, Light-Emitting Device, Display Device, Electronic Device, Light-Emitting Apparatus, and Lighting Device | CCND1, CCND2, DRD1 | NPC1 4220/4885POLB 2617/4885RAB9A 2153/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.